Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs NVTS✓SelectedUSD · NVTSMRNA vs NVTS performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs NVTS

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
NVTS return
-13.4%
Excess return
+160.4%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioNVTSExcessAlpha
1D-2.2%-15.2%+13.0%-0.7%
7D-12.7%-32.1%+19.4%-9.5%
30D-20.7%-33.6%+13.0%-17.5%
3M+46.3%-53.1%+99.4%+56.4%
6M+305.2%-73.6%+378.8%+350.3%
YTD+561.2%-14.8%+576.1%+547.8%
1Y+772.1%-19.5%+791.6%+757.7%
3Y+147.0%-14.2%+161.2%+126.7%
All+147.0%-13.4%+160.4%+126.7%

Cumulative growth

Daily Returns

Daily percentage return beside NVTS.

Daily Out/Under-Performance

Portfolio return minus NVTS return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × NVTS return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded NVTS wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling